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OBSERVATIONS
Fructose-Induced
Hyperuricemia Is
Associated With a
Decreased Renal
Uric Acid Excretion
in Humans
Ingestion of a high-fructose meal in-creases blood uric acid (UA) con-centration in healthy subjects (1).
Furthermore, high-fructose intake over
several days is associated with increased
fasting UA concentration (1). These effects
are generally attributed to an increased
UA production, as observed after intrave-
nous fructose administration (2). It has
not been assessed, however, whether UA
also increases when fructose is adminis-
tered as several small drinks instead of
one single large load or whether a high-
fructose diet (HFrD) impairs renal UA
clearance (UAC) or fractional excretion
(UAFE) as observed in rats (3). We there-
fore measured blood and urine UA and
creatinine concentrations (RX Monza;
Randox Laboratories, London, U.K.) and
calculated UAC and UAFE in 16 healthy
male subjects (mean6 SD age 22.66 2.9,
weight 69.7 6 6.9 kg, BMI 22.1 6 1.8
kg/m2, mean fat-free mass [FFM] 57.86
5.4 kg) over a 9-h period during which
they drank lemon-ﬂavored beverages pro-
viding 0.2 g fructose/kg FFM every hour.
These samples were collected while sub-
jects were participating in two clinical
trials (clinical trial reg. nos. NCT01121003
and NCT01119989; clinicaltrials.gov) that
assessed different metabolic effects of
HFrD but with very similar experimental
designs (4,5). Each subject was studied
twice after 1) 4–6 days on an isoenergetic,
low-fructose diet (LFrD) (n 5 16) and ei-
ther 2) 6 days on a hyperenergetic HFrD
with 34% excess energy as fructose (n5 8)
or 3) 4 days on an weight maintenance
HFrD in which 30% starch was substituted
with fructose (n 5 8). Because an initial
repeated-measures ANOVA did not reveal
any signiﬁcant interaction between diet
and energy content, all HFrD data were
pooled to speciﬁcally test the hypothesis
that HFrD decreased UAC and UAFE.
Although the cumulative fructose load
was large (1.8 g/kg FFM), blood UA con-
centration did not increase above fasting
values, irrespective of the diet consumed
in the days before (Fig. 1A), suggesting
that UA production increases mainly
when the rate of hepatic fructose meta-
bolism is abnormally high. Urinary UA
excretion was not different after HFrD
and LFrD (Fig. 1B), but fasting blood UA
concentration was 18% higher (P5 0.004)
(Fig. 1A), urinary UAC was 9.8 6 21%
lower (P 5 0.015) (Fig. 1C), and UAFE
was 11.5 6 29.2% lower (P 5 0.041)
(Fig. 1D) after HFrD. Creatinine clearance
was not altered by HFrD (LFrD vs. HFrD
1536 39 vs. 1586 19mL/min, P5 0.62)
(data not shown). These observations sug-
gest that a decreased urinary UA excretion
may contribute to fructose-induced hyper-
uricemia. This mechanism may substan-
tially enhance the risk of gout in people
who consume high amounts of sugar. Be-
cause the metabolic effects of fructose
show signiﬁcant sex differences, it
remains to be assessed whether the same
effects are observed in female subjects.
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Figure 1—A: Effect of 4–6 days of an HFrD on blood UA concentrations during a 9-h test of
0.2 g/kg FFM fructose ingested every hour.○ and●, subjects receiving a hyperenergetic diet in
the HFrD condition (HFrD-Hyper trial);□ and▪, subjects receiving an isoenergetic diet in the
HFrD condition (HFrD-Iso trial). Open symbols indicate data collected after 4–6 days of an
isocaloric LFrD in either trial (LFrD-Hyper, LFrD-Iso). Closed symbols represent data collected
after 4–6 days of HFrD. Data are mean6 SD. *Fasting values signiﬁcantly (P, 0.05) different
in subjects receiving an LFrD after the HFrD-Hyper trial. #Fasting values signiﬁcantly (P ,
0.05) different in subjects receiving an LFrD after the HFrD-Iso trial. B: Urinary UA excretion
rate. C: UAC rate. D: UAFE. Data are mean 6 SD. *Signiﬁcant difference between HFrD and
LFrD (pooled data P , 0.05).
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proﬁt, and the work is not altered. See http://
creativecommons.org/licenses/by-nc-nd/3.0/ for
details.
Acknowledgments—This study was sup-
ported by grant 320030-138428 from the
Swiss National Foundation for Science and
by a grant from Ajinomoto Co. Inc., Japan.
L.T. received research support from
Ajinomoto Co. Inc. for the clinical trial
NCT01119989, and from Nestec S.A. for
clinical trials unrelated to this work. No other
potential conﬂicts of interest relevant to this
article were reported.
V.L. and L.E. performed the statistical
analysis. V.L., L.E., F.T., C.D., P.S., and L.T.
revised the manuscript. V.L. and L.T. designed
the study and drafted the manuscript. L.E.,
F.T., and P.S. recruited subjects and performed
the tests and laboratory analyses. C.D. analyzed
dietary intakes. L.T. is the guarantor of this work
and, as such, had full access to all the data in the
study and takes responsibility for the integrity
of the data and the accuracy of the data analysis.
Parts of this study were presented in abstract
form at Experimental Biology 2013, Boston,
Massachusetts, 20–24 April 2013.
c c c c c c c c c c c c c c c c c c c c c c c c
References
1. Cox CL, Stanhope KL, Schwarz JM, et al.
Consumption of fructose- but not glucose-
sweetened beverages for 10weeks increases
circulating concentrations of uric acid, ret-
inol binding protein-4, and gamma-
glutamyl transferase activity in overweight/
obese humans. Nutr Metab (Lond) 2012;
9:68
2. Abdelmalek MF, Lazo M, Horska A, et al.;
Fatty Liver Subgroup of Look AHEAD
Research Group. Higher dietary fructose is
associated with impaired hepatic adenosine
triphosphate homeostasis in obese individuals
with type 2 diabetes. Hepatology 2012;56:
952–960
3. Hu QH, Wang C, Li JM, Zhang DM, Kong
LD. Allopurinol, rutin, and quercetin atten-
uate hyperuricemia and renal dysfunction
in rats induced by fructose intake: renal
organic ion transporter involvement. Am J
Physiol Renal Physiol 2009;297:F1080–
F1091
4. Egli L, Lecoultre V, Theytaz F, et al. Exercise
prevents fructose-induced hypertriglyceri-
demia in healthy young subjects. Diabetes
2013;62:2259–2265
5. Theytaz F, Noguchi Y, Egli L, et al. Effects
of supplementation with essential amino
acids on intrahepatic lipid concentrations
during fructose overfeeding in humans.
Am J Clin Nutr 2012;96:1008–1016
e150 DIABETES CARE, VOLUME 36, SEPTEMBER 2013 care.diabetesjournals.org
Online Letters
